全文获取类型
收费全文 | 424篇 |
免费 | 26篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 8篇 |
妇产科学 | 14篇 |
基础医学 | 35篇 |
口腔科学 | 5篇 |
临床医学 | 65篇 |
内科学 | 115篇 |
皮肤病学 | 1篇 |
神经病学 | 21篇 |
特种医学 | 15篇 |
外科学 | 62篇 |
预防医学 | 21篇 |
眼科学 | 1篇 |
药学 | 18篇 |
肿瘤学 | 62篇 |
出版年
2023年 | 3篇 |
2022年 | 4篇 |
2021年 | 4篇 |
2020年 | 12篇 |
2019年 | 8篇 |
2018年 | 12篇 |
2017年 | 15篇 |
2016年 | 7篇 |
2015年 | 9篇 |
2014年 | 20篇 |
2013年 | 14篇 |
2012年 | 29篇 |
2011年 | 22篇 |
2010年 | 14篇 |
2009年 | 13篇 |
2008年 | 23篇 |
2007年 | 24篇 |
2006年 | 25篇 |
2005年 | 25篇 |
2004年 | 33篇 |
2003年 | 16篇 |
2002年 | 18篇 |
2001年 | 6篇 |
2000年 | 5篇 |
1999年 | 5篇 |
1998年 | 6篇 |
1997年 | 2篇 |
1996年 | 4篇 |
1995年 | 4篇 |
1994年 | 3篇 |
1993年 | 2篇 |
1992年 | 3篇 |
1991年 | 2篇 |
1990年 | 7篇 |
1989年 | 10篇 |
1988年 | 7篇 |
1987年 | 5篇 |
1986年 | 5篇 |
1985年 | 5篇 |
1984年 | 6篇 |
1983年 | 2篇 |
1982年 | 2篇 |
1981年 | 1篇 |
1977年 | 2篇 |
1976年 | 1篇 |
1971年 | 1篇 |
1931年 | 1篇 |
1930年 | 1篇 |
1929年 | 2篇 |
1907年 | 1篇 |
排序方式: 共有451条查询结果,搜索用时 15 毫秒
131.
Giulio Gaist Giancarlo Piazza Ercole Galassi Carlo Cavina Gian Paolo Salvioli 《Child's nervous system》1987,3(6):327-333
Craniopagus twinning is an extremely uncommon birth defect with an estimated incidence of 4–6 every 10 million births. The most complex and challenging issue is the feasibility of surgical separation, which involves not only technical but also socioethical problems and requires strict multidisciplinary cooperation between pediatricians, neuroradiologists, anesthesiologists, and plastic and neurological surgeons. The authors report a case in which separation was followed by the death of both twins and stress the importance, from the surgical and prognostic viewpoints, of the degree of vascular connections between the major dural sinuses, We propose a classification into three types according to severity. 相似文献
132.
133.
Catechol ortho-quinones: the electrophilic compounds that form depurinating DNA adducts and could initiate cancer and other diseases 总被引:7,自引:0,他引:7
Cavalieri EL Li KM Balu N Saeed M Devanesan P Higginbotham S Zhao J Gross ML Rogan EG 《Carcinogenesis》2002,23(6):1071-1077
Catechol estrogens and catecholamines are metabolized to quinones, and the metabolite catechol (1,2-dihydroxybenzene) of the leukemogenic benzene can also be oxidized to its quinone. We report here that quinones obtained by enzymatic oxidation of catechol and dopamine with horseradish peroxidase, tyrosinase or phenobarbital-induced rat liver microsomes react with DNA by 1,4-Michael addition to form predominantly depurinating adducts at the N-7 of guanine and the N-3 of adenine. These adducts are analogous to the ones formed with DNA by enzymatically oxidized 4-catechol estrogens (Cavalieri,E.L., et al. (1997) PROC: Natl Acad. Sci., 94, 10937). The adducts were identified by comparison with standard adducts synthesized by reaction of catechol quinone or dopamine quinone with deoxyguanosine or adenine. We hypothesize that mutations induced by apurinic sites, generated by the depurinating adducts, may initiate cancer by benzene and estrogens, and some neurodegenerative diseases (e.g. Parkinson's disease) by dopamine. These data suggest that there is a unifying molecular mechanism, namely, formation of specific depurinating DNA adducts at the N-7 of guanine and N-3 of adenine, that could initiate many cancers and neurodegenerative diseases. 相似文献
134.
135.
136.
137.
138.
Efficacy of pipobroman in the treatment of polycythemia vera: long-term results in 163 patients 总被引:1,自引:0,他引:1
Passamonti F Brusamolino E Lazzarino M Baraté C Klersy C Orlandi E Canevari A Castelli G Merante S Bernasconi C 《Haematologica》2000,85(10):1011-1018
BACKGROUND AND OBJECTIVES. Polycythemia vera (PV) is a myeloproliferative disorder, characterized by the expansion of the red cell mass. Our purpose was to evaluate the efficacy of pipobroman (PB) in the long-term control of PV and to assess early and late events. DESIGN AND METHODS. From June 1975 to December 1997, 163 untreated patients with PV (median age 57 years, range 30-82) were treated with PB in a single Institute for a median follow-up of 120 months. The diagnosis was made according to the Polycythemia Vera Study Group criteria. PB was given at the dose of 1 mg/kg/day until hematologic response (hematocrit < 45% and platelets < 400x109/L) and of 0.3-0.6 mg/kg/day as maintenance therapy. RESULTS. Hematologic remission was achieved in 94% of patients in a median time of 13 weeks (range 6-48). Median overall survival was 215 months, with a standardized mortality ratio of 1.7. The cumulative risk of death was 11%, 22%, and 26% at 7, 10, and 12 years, respectively. The incidence of thrombotic events was 18.4x105 person-year and the cumulative risk was 6%, 11%, 16%, and 20% at 3, 7, 10, and 12 years respectively. Acute leukemia occurred in 11 patients, myelofibrosis in 7, and solid tumors in 11. The 10-year cumulative risk of leukemia, myelofibrosis, and solid tumors was 5%, 4%, and 8%, respectively. In the logistic analysis age over 65 (p = 0.0001) and thrombotic events at diagnosis (p = 0.001) were significantly correlated with a higher risk of death. Female gender (p = 0.02) and age over 65 (p = 0.01) significantly influenced the occurrence of thrombotic complications. Age was the only significant risk factor for leukemia (p = 0.04) and for solid tumors (p = 0.03), while the duration of PB treatment did not influence these risks. No significant risk factor was demonstrated for myelofibrosis. INTERPRETATION AND CONCLUSIONS. This study demonstrates in a large series of patients, observed for a long period, that pipobroman is effective in the long-term control of PV. The risk of early thrombotic complications at 3 years is 6% and the 10-year risk of acute leukemia, late myelofibrosis, and solid tumors is 5%, 4%, and 8%, respectively. The duration of pipobroman treatment did not correlate with these events. 相似文献
139.